Next-Generation Electrical Stimulation Therapy Systems

Publication ID: 24-11857785_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Electrical Stimulation Therapy Systems,” Published Technical Disclosure No. 24-11857785_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857785_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,785.

Summary of the Inventive Concept

The present inventive concept envisions a next-generation electrical stimulation therapy system that leverages advanced technologies, such as adaptive energy harvesting, artificial intelligence, and blockchain, to provide personalized, real-time, and adaptive treatment for various medical conditions.

Background and Problem Solved

The original patent disclosed systems, methods, and devices for electrical stimulation therapy, primarily focusing on transcutaneous devices for enhancing bone healing in spinal fusion patients. However, these systems have limitations, such as battery replacement and recharging issues, lack of personalization, and limited data analytics capabilities. The new inventive concept addresses these limitations by introducing novel features that enhance treatment efficacy, patient comfort, and data security.

Detailed Description of the Inventive Concept

The next-generation electrical stimulation therapy system comprises a wearable, implantable, or injectable device with a biocompatible, adaptive, and self-sustaining energy harvesting system that eliminates the need for battery replacement or recharging. The system utilizes artificial intelligence, machine learning, and data analytics to optimize stimulation parameters based on a patient's unique physiological response, medical history, and lifestyle factors. Additionally, the system includes a neural interface with a high-resolution, implantable electrode array for precise, targeted, and adaptive stimulation of specific neural pathways. A decentralized, blockchain-based platform ensures secure, transparent, and patient-centric data management and treatment planning.

Novelty and Inventive Step

The new inventive concept introduces several novel features that distinguish it from the original patent, including adaptive energy harvesting, artificial intelligence-driven optimization, and blockchain-based data management. These advancements provide a significant inventive step, as they enable more efficient, personalized, and secure electrical stimulation therapy.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the type of energy harvesting (e.g., solar, kinetic, or biochemical), using different machine learning algorithms, or incorporating additional sensors or interfaces (e.g., EEG or EMG). These variations could be tailored to specific medical conditions, patient populations, or treatment settings.

Potential Commercial Applications and Market

The next-generation electrical stimulation therapy system has significant commercial potential in various markets, including pain management, physical therapy, and neurology. The system's advanced features and personalized approach could attract patients and healthcare providers seeking more effective and efficient treatment options. The decentralized, blockchain-based platform could also enable new business models and revenue streams for data analytics, remote monitoring, and personalized treatment planning.

Original Patent Information

Patent NumberUS 11,857,785
TitleSystems, methods and devices for electrical stimulation therapy
Assignee(s)Theragen, Inc.